Sources | Names Used |
---|---|
CTRPv2 | BRD9876:MK-1775 (4:1 mol/mol) |
PharmacoGx | BRD9876:MK-1775 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CEP250 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.001 |
mRNA | CEBPG | CTRPv2 | pan-cancer | AAC | 0.36 | 0.001 |
mRNA | RECQL4 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.002 |
mRNA | SMC1A | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |
mRNA | ZNF84 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |
mRNA | IPO9 | CTRPv2 | pan-cancer | AAC | 0.38 | 0.002 |
mRNA | RFWD2 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.002 |
mRNA | TBC1D3K | CTRPv2 | pan-cancer | AAC | -0.34 | 0.002 |
mRNA | HFM1 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |
mRNA | HNRNPA1L2 | CTRPv2 | pan-cancer | AAC | 0.44 | 0.002 |